Comprehensive Review of Methods to Assess Uncertainty in Health Economic Evaluations
As healthcare costs continue to rise, accurate cost-effectiveness estimates are crucial. However, estimating the costs and outcomes of different interventions is complicated by uncertainty.
In model-based health economic evaluations (HEEs), uncertainty can arise from limited data, methodological limitations, and variability in clinical outcomes.
A recent review identified 80 methods for identifying, analyzing, and communicating uncertainty in HEEs. Quantifying uncertainty wherever possible is crucial to ensure accurate and unbiased cost-effectiveness estimates, ultimately leading to optimal allocation of healthcare resources
Recent Posts
South Africa Health Reform: Navigating Innovations and Challenges for 2026
South Africa Health Reform: Contrasts in 2026 Public Health Agenda
South Africa health reform defines the 2026 public health landscape as a mix of breakthroughs like HIV prevention injections and AI-driven TB diagnos...
Enhancing Early-Stage Cancer Treatment: Overcoming Barriers for Better Outcomes
Unlocking Early-Stage Cancer Treatment Gains
Early-stage cancer treatment offers significant clinical, humanistic, and economic advantages through timely detection and intervention, yet faces barriers like screening disparities, recurren...
European Pharma Competitiveness: A Cornerstone for EU Economic Resilience
European Pharma Competitiveness: Driving EU Economic Strength
European pharma competitiveness is vital for the EU's trade surplus and future growth. How does the pharmaceutical sector boost EU competitiveness? It generate...